Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP
Clinical trial NCT01225276 · TERMINATED
Trial details
- NCT number
- NCT01225276
- Sponsor
- Octapharma
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2012-10-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.